Total Funding
80
68
Total FundingSeed raised
Growth Score
-7 pts
Heat Score
-2 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
17348
Clinical decision support platform for pharmacogenomics, medication safety, and real-world evidence.
- Mike Zack: CEO
- Allan Gobbs: Executive ChairmanPast Role: Barclays Investment Bank, VP, M&A/IPO
About the Company
PGxAI is a clinical decision support platform for precision prescribing. It combines pharmacogenomics, medication interaction risk, clinical context, multi-omics, and real-world evidence to deliver evidence-linked drug, dose, monitoring, and safer-alternative actions inside EHR workflows. The platform supports health systems, labs,
biopharma/CROs, payors, and patients with governed learning loops, FHIR/HL7/CDS integration pathways, auditability, and enterprise rollout controls.
